While E2F3 expression in TAMR-1 cells was not previously determined, previous studies reported that E2F3 expression was elevated in paclitaxel-resistant MCF-7 cells, as well as different resistant cancer types, including ovarian and lung cancer cells [47–49]. This evidence concerns the gene E2F3 and lung carcinoma.